ELEVANCE HEALTH, INC. (ELV) FY2024 Annual Balance Sheet

ELEVANCE HEALTH, INC. (ELV) FY2024 Annual Balance Sheet

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

Assets

116,889,000,000 US dollars

Current assets

58,942,000,000 US dollars

Non-current assets

57,947,000,000 US dollars

Liabilities

75,463,000,000 US dollars

Current liabilities

40,581,000,000 US dollars

Non-current liabilities

34,882,000,000 US dollars

Equity

41,426,000,000 US dollars

Noncontrolling interest

111,000,000 US dollars. Included in consolidated equity; this amount is not added again.

Fixed maturity securities (amortized cost of $25,879 and $30,446; allowance for credit losses of $6 and $4)

25,201,000,000 US dollars

Cash and cash equivalents

8,288,000,000 US dollars

Premium receivables

8,011,000,000 US dollars

Other receivables

6,016,000,000 US dollars

Self-funded receivables

5,044,000,000 US dollars

Other current assets

4,700,000,000 US dollars

Equity securities

1,192,000,000 US dollars

Assets held for sale

490,000,000 US dollars

Goodwill

28,277,000,000 US dollars

Other intangible assets

12,094,000,000 US dollars

Other invested assets

9,749,000,000 US dollars

Property and equipment, net

4,652,000,000 US dollars

Other noncurrent assets

2,140,000,000 US dollars

Fixed maturity securities (amortized cost of $1,049 and $890; allowance for credit losses of $0 and $0)

1,035,000,000 US dollars

Medical claims payable

15,746,000,000 US dollars

Other current liabilities

10,029,000,000 US dollars

Accounts payable and accrued expenses

6,927,000,000 US dollars

Other policyholder liabilities

4,204,000,000 US dollars

Current portion of long-term debt

1,649,000,000 US dollars

Unearned income

1,508,000,000 US dollars

Short-term borrowings

365,000,000 US dollars

Liabilities held for sale

153,000,000 US dollars

Long-term debt, less current portion

29,218,000,000 US dollars

Other noncurrent liabilities

3,326,000,000 US dollars

Deferred tax liabilities, net

2,148,000,000 US dollars

Reserves for future policy benefits

190,000,000 US dollars

Retained earnings

33,549,000,000 US dollars

Additional paid-in capital

8,911,000,000 US dollars

Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 227,479,695 and 233,071,088

2,000,000 US dollars

Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none

0 US dollars

Noncontrolling interests

111,000,000 US dollars

Accumulated other comprehensive loss

negative 1,147,000,000 US dollars

Gross equity (calculated)

42,573,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.